TaiwanJ Pharmaceuticals Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 22.06 million. Net loss was TWD 12.42 million compared to TWD 42.46 million a year ago. Basic loss per share from continuing operations was TWD 0.17 compared to TWD 0.6 a year ago. Diluted loss per share from continuing operations was TWD 0.17 compared to TWD 0.6 a year ago.